KDx Diagnostics Announces CE Marking for Innovative Non-invasive URO17™ Bladder Cancer Test
KDx Diagnostics, Inc., announced today that it has received Conformité Européene (CE) Marking for its innovative and proprietary urine-based test (the URO17™ test) for bladder cancer... more
KDx Diagnostics announces FDA Breakthrough Device designation for URO17™, Innovative urine test
CAMPBELL, Calif., Jan. 8, 2020 /PRNewswire/ -- KDx Diagnostics, Inc. (KDx), announced today that the Food and Drug Administration (FDA) has granted "Breakthrough Device" designation for its URO17™ Bladder Cancer Recurrence Test... more
Demonstration of Keratin 17 Biomarker for Urothelial Carcinoma Detection
Bladder carcinoma is a common urological cancer with high morbidity, mortality, and recurrence rates requiring frequent, invasive diagnostic procedures...more(1) more(2)
A Better Future
A new biomarker allows effective, noninvasive screening of patients at risk of the disease. Bladder cancer presents a diagnostic challenge for even the best pathologists and laboratory medicine professionals...more
Acupath First Commercial Lab to Offer URO17™, Innovative New Biomarker
PLAINVIEW, N.Y. and CAMPBELL, Calif., July 25, 2019 /PRNewswire/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, and KDx Diagnostics, Inc., a leading developer of bladder cancer tests, today announced that KDx has licensed Acupath to incorporate its URO17™ ...more
Validation of a Novel Cytologic Biomarker for Urothelial Carcinoma
and cystoscopy have limited sensitivity and specificity for the diagnosis of urothelial carcinoma ( due to inflammatory atypia, sampling errors, and other clinicopathologic factors that may...more
Keratin 17 is a Sensitive and Specific Biomarker of Urothelial Neoplasia
The current study aimed to evaluate keratin 17 (K17), an oncoprotein that drives cell cycle progression in cancers of multiple anatomic sites as a diagnostic biomarker of urothelial neoplasia in bladder biopsies and in urine cytology specimens...more
Keratin 17 is a sensitive and specific biomarker of urothelial
There is a clinical need to identify novel biomarkers to improve diagnostic accuracy for the detection of urothelial tumors.
The current study aimed to evaluate keratin 17 (K17), an oncoprotein that drives cell cycle progression in cancers...more
EAU'20 ( Cancelled Event Due to COVID-19)
The biggest urological event in Europe
LUGPA is the only nonprofit urology trade association in the US.
A non-profit organization (501 c6) composed of Urologists and Urology professionals joining together to further their mission.